These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 29191656)
1. Overexpression of microRNA-26a protects against deficient β-cell function via targeting phosphatase with tensin homology in mouse models of type 2 diabetes. Song Y; Jin D; Jiang X; Lv C; Zhu H Biochem Biophys Res Commun; 2018 Jan; 495(1):1312-1316. PubMed ID: 29191656 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function. Xu H; Du X; Xu J; Zhang Y; Tian Y; Liu G; Wang X; Ma M; Du W; Liu Y; Dai L; Huang W; Tong N; Wei Y; Fu X PLoS Biol; 2020 Feb; 18(2):e3000603. PubMed ID: 32092075 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-26a overexpression protects RGC-5 cells against H2O2-induced apoptosis. Kang Y; Jia P; Zhao H; Hu C; Yang X Biochem Biophys Res Commun; 2015 May; 460(2):164-9. PubMed ID: 25757910 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of miR-26a promotes neurite outgrowth and ameliorates apoptosis by inhibiting PTEN in bupivacaine injured mouse dorsal root ganglia. Cui C; Xu G; Qiu J; Fan X Cell Biol Int; 2015 Aug; 39(8):933-42. PubMed ID: 25808510 [TBL] [Abstract][Full Text] [Related]
5. Deletion of Pten in pancreatic ß-cells protects against deficient ß-cell mass and function in mouse models of type 2 diabetes. Wang L; Liu Y; Yan Lu S; Nguyen KT; Schroer SA; Suzuki A; Mak TW; Gaisano H; Woo M Diabetes; 2010 Dec; 59(12):3117-26. PubMed ID: 20852026 [TBL] [Abstract][Full Text] [Related]
6. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator. Zhuge B; Li G Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687 [TBL] [Abstract][Full Text] [Related]
7. MiR-499-5p Contributes to Hepatic Insulin Resistance by Suppressing PTEN. Wang L; Zhang N; Pan HP; Wang Z; Cao ZY Cell Physiol Biochem; 2015; 36(6):2357-65. PubMed ID: 26279439 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell-conditioned medium alleviates high fat-induced hyperglucagonemia via miR-181a-5p and its target PTEN/AKT signaling. Song J; He Q; Guo X; Wang L; Wang J; Cui C; Hu H; Yang M; Cui Y; Zang N; Yan F; Liu F; Sun Y; Liang K; Qin J; Zhao R; Wang C; Sun Z; Hou X; Li W; Chen L Mol Cell Endocrinol; 2021 Nov; 537():111445. PubMed ID: 34464683 [TBL] [Abstract][Full Text] [Related]
9. MiR-26a promotes neurite outgrowth by repressing PTEN expression. Li B; Sun H Mol Med Rep; 2013 Aug; 8(2):676-80. PubMed ID: 23783805 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids. Fu X; Dong B; Tian Y; Lefebvre P; Meng Z; Wang X; Pattou F; Han W; Wang X; Lou F; Jove R; Staels B; Moore DD; Huang W J Clin Invest; 2015 Jun; 125(6):2497-509. PubMed ID: 25961460 [TBL] [Abstract][Full Text] [Related]
11. LncRNA UCA1 sponges miR-26a to regulate the migration and proliferation of vascular smooth muscle cells. Tian S; Yuan Y; Li Z; Gao M; Lu Y; Gao H Gene; 2018 Oct; 673():159-166. PubMed ID: 29908280 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-96 regulates pancreatic β cell function under the pathological condition of diabetes mellitus through targeting Foxo1 and Sox6. Qi H; Yao L; Liu Q Biochem Biophys Res Commun; 2019 Nov; 519(2):294-301. PubMed ID: 31506178 [TBL] [Abstract][Full Text] [Related]
13. MiR-26a inhibits proliferation and migration of HaCaT keratinocytes through regulating PTEN expression. Yu N; Yang Y; Li X; Zhang M; Huang J; Wang X; Long X Gene; 2016 Dec; 594(1):117-124. PubMed ID: 27613140 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA TUG1 acts as a miR-26a sponge in human glioma cells. Li J; An G; Zhang M; Ma Q Biochem Biophys Res Commun; 2016 Sep; 477(4):743-748. PubMed ID: 27363339 [TBL] [Abstract][Full Text] [Related]
15. Abnormal Expression of microRNA-296-3p in Type 2 Diabetes Patients and its Role in Pancreatic β-Cells Function by Targeting Tensin Homolog Deleted on Chromosome Ten. Cheng M; Guo Y; Zhong W; Chen X; Guo G Biochem Genet; 2022 Feb; 60(1):39-53. PubMed ID: 34085179 [TBL] [Abstract][Full Text] [Related]
16. Targeted Regulation of miR-26a on PTEN to Affect Proliferation and Apoptosis of Prostate Cancer Cells. Li W; Jiang Y; Wu X; Yang F Cancer Biother Radiopharm; 2019 Sep; 34(7):480-485. PubMed ID: 31135180 [No Abstract] [Full Text] [Related]
17. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Liu B; Wu X; Liu B; Wang C; Liu Y; Zhou Q; Xu K Biochim Biophys Acta; 2012 Nov; 1822(11):1692-704. PubMed ID: 22885155 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-26a regulates cerebral ischemia injury through targeting PTEN. Guo XL; Liang H; Sun Y; Wang CB Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):7033-7041. PubMed ID: 31486504 [TBL] [Abstract][Full Text] [Related]
19. MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue. Ling HY; Hu B; Hu XB; Zhong J; Feng SD; Qin L; Liu G; Wen GB; Liao DF Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):553-9. PubMed ID: 22956257 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion. Sebastiani G; Po A; Miele E; Ventriglia G; Ceccarelli E; Bugliani M; Marselli L; Marchetti P; Gulino A; Ferretti E; Dotta F Acta Diabetol; 2015 Jun; 52(3):523-30. PubMed ID: 25408296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]